Greater Houston Section

May Seminar (Hybrid) - Michael Liebman

  • 24 May 2023
  • 7:00 PM - 8:00 PM
  • Zoom & St. John's School, 2401 Claremont Ln, Houston, TX 77019

Registration is closed

May Seminar (Hybrid) - Michael Liebman

Managing Director/Professor, IPQ Analytics, LLC

Adjunct Professor, Drexel College of Medicine & Fudan University

Wednesday, May 24, 2023

6:30 - 7:00 pm - Dinner (in-person only)

7:00 - 8:00 pm - Seminar

Via Zoom or In Person

Download the Seminar Flyer

Online: Free! Enjoy Michael Liebman's presentation via Zoom at home or wherever you are.

Register using the button on the left to receive the Zoom link by email


In-Person ($10/person): Join us at St. John's School at 6:30 pm for dinner, followed by watching Dr. Liebman's seminar in a social setting. Ticket includes dinner and networking. Please email with any dietary restrictions.

St. John's School

Building E (Mewbourne Bldg), Room M202

2401 Claremont Lane

Houston, TX  77019

Dinner ticket purchases now closed

Enter from Gate 1 (northeast corner of Westheimer and Buffalo Speedway). Parking is available under Building A. The seminar will be held in Building E, Room M202. A campus map is available at

Decision Making in Drug Development and Medicine:

The Good, the Bad, the Ugly

Critical analysis of the decision-making processes and the application of systems thinking and critical thinking are needed to understand the full impact of factors beyond "the chemistry" and build models to represent and analyze the full complexity. Such factors can range from real world data to public health to political and economic constraints. This seminar will also discuss how to move beyond the hype to the real world.

Biography: Michael N. Liebman, Ph.D (theoretical chemistry and protein crystallography) is the Managing Director of IPQ Analytics, LLC and Strategic Medicine, Inc after serving as the Executive Director of the Windber Research Institute (now Chan Soon-Shiong Institute for Molecular Medicine) from 2003-2007. He is an Adjunct Professor of Pharmacology and Physiology at Drexel College of Medicine and Adjunct Professor of Drug Discovery, First Hospital of Wenzhou Medical University and also Fudan University. He serves on the Advisory Board for the International Park for Translational Biomedicine (Shanghai) and the Center of Biomedical and Health Research in Data Sciences, Univ Massachusetts (Lowell). His research focuses on computational models of disease progression that stress risk detection, disease processes and clinical pathway modeling, and disease stratification from the clinical perspective. He utilizes systems-based approaches and design thinking to represent and analyze risk/benefit analysis in pharmaceutical development and healthcare and reimbursement. Current application areas include: multiple sclerosis, heart failure, triple negative breast cancer, COVID and prematurity/infant-maternal morbidity and mortality.
Powered by Wild Apricot Membership Software